• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过主客体识别和金属配位对肿瘤微环境进行超分子调控以增强癌症化学免疫疗法

Supramolecular Modulation of Tumor Microenvironment Through Host-Guest Recognition and Metal Coordination to Potentiate Cancer Chemoimmunotherapy.

作者信息

Wu Dan, Zhou Jie, Zhang Zhankui, Cao Yibin, Ping Kunmin, Qi Shaolong, Du Jianshi, Yu Guocan

机构信息

College of Materials Science and Engineering, Zhejiang University of Technology, Hangzhou, 310014, P. R. China.

Vascular Surgery Center, The Third Hospital of Jilin University, Changchun, 130031, P. R. China.

出版信息

Adv Sci (Weinh). 2025 Mar;12(11):e2408518. doi: 10.1002/advs.202408518. Epub 2025 Jan 30.

DOI:10.1002/advs.202408518
PMID:39887941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11923969/
Abstract

The massive amount of indoleamine 2,3-dioxygenase 1 (IDO-1) in tumor cells and tumor-associated immune cells forms a feedback loop that maintains immunosuppressive tumor microenvironment (ITM) and causes immune escape, resulting in the poor prognosis of platinum chemotherapeutics. However, the effective systemic administration of platinum drugs and IDO-1 inhibitors is strictly limited by their distinct chemical construction, different pharmacokinetic profiles, and heterogeneous distributions. Herein, a novel supramolecular method with the capability to modulate tumor microenvironment is proposed aiming at potentiating the antitumor efficacy of chemoimmunotherapy. Profiting from the dynamic and reversible merits of noncovalent interactions, IDO-1 inhibitor (IDOi) and 1,2-diaminocyclohexane-platinum(II) (DACHPt) are tailor-encapsulated into supramolecular nanoparticles (SNPs) with the aid of host-guest recognition and metal coordination, respectively, effectively increasing the drug loading and improving their pharmacokinetics. In addition to the authorized chemotherapeutical effect, DACHPt performs a systemic antitumor immune response, which is further magnified by the IDOi-reversed ITM to encourage T lymphocyte infiltration, guaranteeing long-term antitumor immune responses to improve cancer prognosis.

摘要

肿瘤细胞和肿瘤相关免疫细胞中大量的吲哚胺2,3-双加氧酶1(IDO-1)形成了一个反馈回路,维持免疫抑制性肿瘤微环境(ITM)并导致免疫逃逸,从而导致铂类化疗药物预后不良。然而,铂类药物和IDO-1抑制剂的有效全身给药受到其独特化学结构、不同药代动力学特征和异质分布的严格限制。在此,提出了一种具有调节肿瘤微环境能力的新型超分子方法,旨在增强化学免疫疗法的抗肿瘤疗效。借助非共价相互作用的动态和可逆优点,IDO-1抑制剂(IDOi)和1,2-二氨基环己烷-铂(II)(DACHPt)分别通过主客体识别和金属配位被定制封装到超分子纳米颗粒(SNP)中,有效提高了药物负载量并改善了它们的药代动力学。除了已证实的化疗效果外,DACHPt还能引发全身性抗肿瘤免疫反应,IDOi逆转的ITM进一步放大了这种反应,以促进T淋巴细胞浸润,确保长期的抗肿瘤免疫反应以改善癌症预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd48/11923969/81129b6efc18/ADVS-12-2408518-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd48/11923969/b4356f1a1d75/ADVS-12-2408518-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd48/11923969/4e71f657cb3a/ADVS-12-2408518-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd48/11923969/c2d7d7fa269f/ADVS-12-2408518-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd48/11923969/12ee725ff6ac/ADVS-12-2408518-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd48/11923969/4d89a96fe64b/ADVS-12-2408518-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd48/11923969/81129b6efc18/ADVS-12-2408518-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd48/11923969/b4356f1a1d75/ADVS-12-2408518-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd48/11923969/4e71f657cb3a/ADVS-12-2408518-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd48/11923969/c2d7d7fa269f/ADVS-12-2408518-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd48/11923969/12ee725ff6ac/ADVS-12-2408518-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd48/11923969/4d89a96fe64b/ADVS-12-2408518-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd48/11923969/81129b6efc18/ADVS-12-2408518-g005.jpg

相似文献

1
Supramolecular Modulation of Tumor Microenvironment Through Host-Guest Recognition and Metal Coordination to Potentiate Cancer Chemoimmunotherapy.通过主客体识别和金属配位对肿瘤微环境进行超分子调控以增强癌症化学免疫疗法
Adv Sci (Weinh). 2025 Mar;12(11):e2408518. doi: 10.1002/advs.202408518. Epub 2025 Jan 30.
2
Dual-Responsive Supramolecular Polymeric Nanomedicine for Self-Cascade Amplified Cancer Immunotherapy.双重响应超分子聚合物纳米医学用于自我级联放大的癌症免疫治疗。
Adv Sci (Weinh). 2024 May;11(20):e2305382. doi: 10.1002/advs.202305382. Epub 2024 Mar 17.
3
Novel Indoleamine-2,3-Dioxygenase-Targeted Pt(IV) Prodrugs Regulate the Tumor Immune Microenvironment to Achieve Chemoimmunotherapy and .新型吲哚胺-2,3-双加氧酶靶向铂(IV)前药调节肿瘤免疫微环境以实现化学免疫疗法及…… (原文结尾不完整)
J Med Chem. 2025 Feb 27;68(4):4352-4372. doi: 10.1021/acs.jmedchem.4c02116. Epub 2025 Feb 7.
4
Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy.吲哚胺 2,3-双加氧酶(IDO)抑制作为增强癌症免疫治疗的策略。
BioDrugs. 2018 Aug;32(4):311-317. doi: 10.1007/s40259-018-0291-4.
5
Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies.阻断吲哚胺-2,3-双加氧酶的反弹免疫抑制可增强放射性免疫疗法在小鼠模型和自发性犬类恶性肿瘤中的抗肿瘤效果。
Clin Cancer Res. 2016 Sep 1;22(17):4328-40. doi: 10.1158/1078-0432.CCR-15-3026. Epub 2016 Mar 15.
6
Electric Pulse Responsive Magnetic Nanoclusters Loaded with Indoleamine 2,3-Dioxygenase Inhibitor for Synergistic Immuno-Ablation Cancer Therapy.载吲哚胺 2,3-双加氧酶抑制剂的电脉冲响应磁性纳米簇用于协同免疫消融癌症治疗。
ACS Appl Mater Interfaces. 2020 Dec 9;12(49):54415-54425. doi: 10.1021/acsami.0c15679. Epub 2020 Nov 25.
7
Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.基于氧化还原激活卟啉的脂质体远程加载吲哚胺 2,3-双加氧酶 (IDO) 抑制剂用于协同光免疫治疗,通过诱导免疫原性细胞死亡和阻断 IDO 途径。
Nano Lett. 2019 Oct 9;19(10):6964-6976. doi: 10.1021/acs.nanolett.9b02306. Epub 2019 Sep 24.
8
Plasmon-Driven Catalytic Chemotherapy Augments Cancer Immunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.等离子体驱动的催化化疗通过诱导免疫原性细胞死亡和阻断 IDO 途径增强癌症免疫治疗。
Adv Mater. 2021 Aug;33(34):e2102188. doi: 10.1002/adma.202102188. Epub 2021 Jul 18.
9
Engineering a photosensitizer nanoplatform for amplified photodynamic immunotherapy via tumor microenvironment modulation.通过肿瘤微环境调控工程化光敏剂纳米平台用于放大光动力免疫治疗。
Nanoscale Horiz. 2021 Feb 1;6(2):120-131. doi: 10.1039/d0nh00480d. Epub 2020 Nov 18.
10
Bimetallic peroxide-based nanotherapeutics for immunometabolic intervention and induction of immunogenic cell death to augment cancer immunotherapy.用于免疫代谢干预和诱导免疫原性细胞死亡以增强癌症免疫治疗的双金属过氧化物纳米疗法。
Biomaterials. 2025 Apr;315:122934. doi: 10.1016/j.biomaterials.2024.122934. Epub 2024 Oct 30.

本文引用的文献

1
Dual-Responsive Supramolecular Polymeric Nanomedicine for Self-Cascade Amplified Cancer Immunotherapy.双重响应超分子聚合物纳米医学用于自我级联放大的癌症免疫治疗。
Adv Sci (Weinh). 2024 May;11(20):e2305382. doi: 10.1002/advs.202305382. Epub 2024 Mar 17.
2
Supramolecular Genome Editing: Targeted Delivery and Endogenous Activation of CRISPR/Cas9 by Dynamic Host-Guest Recognition.超分子基因组编辑:通过动态主体-客体识别实现 CRISPR/Cas9 的靶向递送和内源性激活。
Angew Chem Int Ed Engl. 2024 Apr 2;63(14):e202316323. doi: 10.1002/anie.202316323. Epub 2024 Feb 29.
3
Supramolecular Nucleic Acid-Based Organosilica Nanoparticles Responsive to Physical and Biological Inputs.
基于超分子核酸的有机硅纳米粒子,对物理和生物输入有响应。
J Am Chem Soc. 2023 Oct 25;145(42):22903-22912. doi: 10.1021/jacs.3c04345. Epub 2023 Oct 16.
4
Self-Cooperative Prodrug Nanovesicles Migrate Immune Evasion to Potentiate Chemoradiotherapy in Head and Neck Cancer.自协作前药纳米囊泡迁移免疫逃避以增强头颈部癌症的放化疗。
Adv Sci (Weinh). 2022 Dec;9(36):e2203263. doi: 10.1002/advs.202203263. Epub 2022 Nov 7.
5
Suprasomes Based on Host-Guest Molecular Recognition: An Excellent Alternative to Liposomes in Cancer Theranostics.基于主客体分子识别的超分子体:癌症诊疗中脂质体的绝佳替代物。
Angew Chem Int Ed Engl. 2022 Dec 23;61(52):e202213572. doi: 10.1002/anie.202213572. Epub 2022 Dec 5.
6
Self-Splittable Transcytosis Nanoraspberry for NIR-II Photo-Immunometabolic Cancer Therapy in Deep Tumor Tissue.自分割型跨细胞纳米覆盆子用于近红外二区光免疫代谢癌症治疗深部肿瘤组织。
Adv Sci (Weinh). 2022 Nov;9(32):e2204067. doi: 10.1002/advs.202204067. Epub 2022 Sep 8.
7
Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy.吲哚胺 2,3-双加氧酶(IDO)抑制剂与癌症免疫治疗。
Cancer Treat Rev. 2022 Nov;110:102461. doi: 10.1016/j.ctrv.2022.102461. Epub 2022 Aug 30.
8
Natural Polyphenols-Platinum Nanocomplexes Stimulate Immune System for Combination Cancer Therapy.天然多酚-铂纳米复合物刺激免疫系统用于联合癌症治疗。
Nano Lett. 2022 Jul 13;22(13):5615-5625. doi: 10.1021/acs.nanolett.2c02161. Epub 2022 Jun 24.
9
Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency.免疫原性细胞死亡激活肿瘤免疫微环境以提高免疫治疗效率。
Adv Sci (Weinh). 2022 Aug;9(22):e2201734. doi: 10.1002/advs.202201734. Epub 2022 Jun 2.
10
Indoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy.吲哚胺 2,3-双加氧酶(IDO)抑制剂及其用于癌症免疫治疗的纳米药物。
Biomaterials. 2021 Sep;276:121018. doi: 10.1016/j.biomaterials.2021.121018. Epub 2021 Jul 12.